Continuous glucose monitoring reveals trade-off between glucose control and daily well-being

New probe to beryllium presented astatine the Annual Meeting of the European Association for the Study of Diabetes (EASD) successful Milan, Italy, Sept. 28–Oct. 2, shows that among radical surviving with benignant 1 oregon benignant 2 diabetes, information from continuous glucose monitoring (CGM) devices paired with regular quality-of-life ratings recovered that days with much wide fluctuating glucose readings (while inactive wrong harmless limits) were followed by days with amended prime of beingness than days with stricter control—suggesting the load of stricter power could forestall individuals from enjoying assorted activities.